Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer | Zendy

Chang Liu | Zendy; Cathy Eng | Zendy; Jianjun Shen | Zendy; Yue Lu | Zendy; Yoko Takata | Zendy; Amir Mehdizadeh | Zendy; George J. Chang | Zendy; Miguel A. Rodrı́guez-Bigas | Zendy; Yanan Li | Zendy; Ping Chang | Zendy; Yixiang Mao | Zendy; Manal M. Hassan | Zendy; Fangyu Wang | Zendy; Donghui Li | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer

Author(s) -

Chang Liu,

Cathy Eng,

Jianjun Shen,

Yue Lu,

Yoko Takata,

Amir Mehdizadeh,

George J. Chang,

Miguel A. Rodrı́guez-Bigas,

Yanan Li,

Ping Chang,

Yixiang Mao,

Manal M. Hassan,

Fangyu Wang,

Donghui Li

Publication year - 2016

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.12841

Subject(s) - medicine , colorectal cancer , adjuvant therapy , biomarker , oncology , microrna , folfox , stage (stratigraphy) , cancer , primary tumor , adjuvant , gastroenterology , metastasis , oxaliplatin , biology , gene , paleontology , biochemistry

The study was aimed to evaluate the prognostic or predictive value of serum exosomal microRNAs (miRNAs) for tumor recurrence and response to adjuvant therapy in stage II and stage III colon cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research